Pfizer Biontech COVID-19 Vaccine Booster Dose

Activity Preview

The U.S. Food and Drug Administration has updated the Pfizer-BioNTech COVID-19 vaccine’s Emergency Use Authorization to include booster doses. This update comes approximately one month after the approval for third doses in immunocompromised patients. We will review the clinical evidence behind why the Centers for Disease Control and Prevention recommends that specific groups receive the booster dose while it is not currently indicated in others. A summary of literature on the booster dose and its safety will be highlighted during the last half of the program.

Learning Objectives

At the completion of this activity, the participant will be able to:

  • List the population groups for which the Pfizer-BioNTech COVID-19 vaccine booster dose is recommended
  • Discuss the efficacy of BNT162-b2
  • Discuss the clinical evidence supporting the Pfizer-BioNTech COVID-19 vaccine booster dose for identified populations
  • Discuss the clinical evidence and safety data for the Pfizer-BioNTech COVID-19 vaccine booster dose

Activity type: Knowledge-based
Target Audience: Pharmacists 

Accreditation Information

ACPE Logo

The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The following archived webinar is approved for 1.25 contact hour of CPE credit (0.125 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-21-375-H06-P.

To obtain credit for completing Pfizer-BioNTech COVID-19 Vaccine Booster Dose: Indications, Vaccine Effectiveness, and Safety  participants will need to watch the archived webinar, complete the assessment with a grade of 70% or better, complete the evaluation questions, and then CLAIM credit. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.    

Initial release date: October 18, 2021
Expiration date: November 1, 2023 - No credit can be claimed after this date

Development

Pfizer-BioNTech COVID-19 Vaccine Booster Dose: Indications, Vaccine Effectiveness, and Safety is an activity for pharmacists developed by the American Pharmacists Association. © 2021 American Pharmacists Association

Disclosures

Dr. Daniel Zlott and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures

Fee

This learning product is free to APhA members and non-members

System Requirements

Computer and internet access are required to complete this activity.  Please visit our website to view the Technology System Requirements in order to have a positive learning experience.

Credit Information

Activity Number Credit Amount Accreditation Period
ACPE# 0202-0000-21-375-H06-P 0.125 CEUs October 18, 2021 - November 01, 2023